PDCD4 and neoplasm: Erioflorin interferes with the interaction of β-TrCP with programmed cell death 4 (Pdcd4), a tumor suppressor, resulting in stabilization of Pdcd4, reducing AP-1- and NF-κB-dependent transcription that alters the cell cycle and inhibits proliferation in vitro [235].